The relationship between different C-peptide level and insulin dose of insulin pump

Abstract

Background This study aims to explore the insulin requirement profiles, and analyze the related factors of type-2 diabetes mellitus (T2DM) with different C-peptide levels on insulin pump therapy. Methods A retrospective study was conducted on 271 T2DM patients treated with insulin pumps from 2016 to 2018. These patients were divided into groups according to the ratio of C-peptide at 2\u2009h after meals to fasting C-peptide (C 2 h/C 0 ), and the dosage of insulin and influencing factors were analyzed. Results In comparing group A (C 2h /C 0 \u2009<\u20092.5) with group B (C 2h /C 0 \u2009≥\u20092.5), the percentage of the base amount in total (%TBa, 0.50\u2009±\u20090.06) in group A was higher than that in group B (0.48\u2009±\u20090.05) ( P \u2009<\u20090.05). Furthermore, there was a correlation between C 2h /C 0 and waist circumference, HbA1c, Fasting Plasma Glucose (FPG) and Blood glucose 2\u2009h after meal (2hPG) ( r \u2009=\u2009−0.137, −0.154, −0.471, and −0.172; all, P \u2009<\u20090.05). The multiple linear regression analysis revealed that BMI and FPG were independent factors of %TBa (β′\u2009=\u20090.124 and 0.144; all, P \u2009<\u20090.05), and BMI and FPG were independent factors of C 2h /C 0 (β′\u2009=\u2009−0.134 and −0.502; all, P \u2009<\u20090.05). Conclusions The basal premeal dose ratio of T2DM with different C-peptide levels differs during intensive insulin pump therapy. Parameters that indicate the glycemic control and β-cell function should be taken into consideration for total insulin requirements.